MREO - Mereo BioPharma Group reports FY results March, 31 2021 05:05 PM Mereo BioPharma Group Mereo BioPharma Group (MREO): FY GAAP EPS of -£0.48.Cash and short-term deposits totaled £23.5 million as of December 31, 2020.Press Release For further details see: Mereo BioPharma Group reports FY results